Generation of induced pluripotent stem cells (UCLi024-A) from a patient with argininosuccinate lyase deficiency carrying a homozygous c.437G > A (p.Arg146Gln) mutation
Summary
Argininosuccinic aciduria (ASA) is a rare inherited metabolic disease caused by argininosuccinate lyase (ASL) deficiency. Patients with ASA present with hyperammonaemia due to an impaired urea cycle pathway in the liver, and systemic disease with epileptic encephalopathy, chronic liver disease, and arterial hypertension. A human induced pluripotent stem cell (iPSC) line from the fibroblasts of a patient with ASA with homozygous pathogenic c.437G > A mutation of hASL was generated. Characterization of the cell line demonstrated pluripotency, differentiation potential and normal karyotype. This cell line, called UCLi024-A, can be utilized for in vitro disease modelling of ASA, and design of novel therapeutics. Crown Copyright © 2024. Published by Elsevier B.V. All rights reserved.
| Authors | Duff C, Islam M, Gagliano O, Pramod H, Rashidi H, Kurian MA, Gissen P, Baruteau J |
|---|---|
| Journal | Stem cell research |
| Publication Date | 2024 Apr;76:103365 |
| PubMed | 38422816 |
| DOI | 10.1016/j.scr.2024.103365 |